Cancer

INDICATION: Melanoma, colorectal cancer

In vitro, cell culture and mouse studies identified an aminopyrimidine-based dual MAPK1/MAPK3 inhibitor that could help treat BRAF-mutant melanoma and colorectal

Read the full 251 word article

User Sign In